Essential hypertension: hemodynamic and therapeutic changes over 20 years

Area of Science:

• Cardiovascular Physiology
• Pharmacology

Background:

• Essential hypertension causes hemodynamic disturbances influenced by age and disease severity.
• A 20-year study revealed a progression from high output/normal resistance to low-flow/high-resistance patterns.
• Conventional antihypertensive treatments did not prevent adverse hemodynamic shifts.

Purpose of the Study:

• To evaluate the hemodynamic effects of vasodilating beta-blockers compared to conventional ones.
• To assess the impact of carvedilol on total peripheral resistance and cardiac function in essential hypertension.

Main Methods:

• Longitudinal follow-up study over 20 years.
• Acute hemodynamic assessment of carvedilol in 18 essential hypertension patients.
• Measurement of cardiac index, stroke index, heart rate, and arteriovenous oxygen difference at rest and during exercise.

Main Results:

• Conventional beta-blockers did not prevent increased total peripheral resistance and reduced cardiac output over 20 years.
• Vasodilating beta-blockers, like carvedilol, acutely reduce total peripheral resistance.
• Carvedilol demonstrated a smaller reduction in cardiac index compared to conventional beta-blockers, with improved arteriovenous oxygen difference.

Conclusions:

• Long-term conventional beta-blocker therapy does not reverse adverse hemodynamic changes in essential hypertension.
• Vasodilating beta-blockers offer a distinct hemodynamic profile, potentially beneficial for managing essential hypertension.
• Carvedilol shows promise in improving peripheral resistance and maintaining cardiac output during exercise.